<SEC-DOCUMENT>0001062993-21-004115.txt : 20210505
<SEC-HEADER>0001062993-21-004115.hdr.sgml : 20210505
<ACCEPTANCE-DATETIME>20210504202210
ACCESSION NUMBER:		0001062993-21-004115
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20210504
FILED AS OF DATE:		20210505
DATE AS OF CHANGE:		20210504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		21890705

	BUSINESS ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><b><font size="5">UNITED STATES</font></b><br><b><font size="5">SECURITIES AND EXCHANGE COMMISSION</font></b><br>Washington, D.C. 20549<br><br><b><font size="5">Form 6-K</font></b><br><br><b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</b><br><b>UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: justify;">For the month of <b>May, 2021</b>.</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Commission File Number: <b>001-40065</b></p>
    <p style="margin-top: 0pt; text-align: center;"><br><br><b><font size="5"><u>IM Cannabis Corp.</u></font></b><br>(Exact Name of Registrant as Specified in Charter)<br><br><b>Kibbutz Glil Yam, Central District, Israel 4690500</b><br>(Address of principal executive offices)</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</p>
    <p style="margin-top: 0pt; text-align: justify;">Form 20-F&#160; &#9744;&#160; Form 40-F &#8864;</p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</p>
    <p style="text-align: justify;"><b>Note</b>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</p>
    <p style="text-align: justify;"><b>Note</b>: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>INCORPORATION BY REFERENCE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Exhibit 99.2 to this Form 6-K of IM Cannabis Corp. (the "Company") is hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-254255) of the Company, as amended or supplemented.</p>
    <p style="text-align: center;"><b>SIGNATURE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 6.08%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 44.56%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;" colspan="2">
                <p><b>IM CANNABIS CORP.</b></p>
            </td>
            <td style="width: 7.6%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 6.08%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 44.56%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;" colspan="2">
                <p>(Registrant)</p>
            </td>
            <td style="width: 7.6%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 6.08%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 44.56%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 6.8%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 34.96%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 7.6%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 6.08%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 1.5pt; vertical-align: top;">
                <p>Date:</p>
            </td>
            <td style="width: 44.56%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 1.5pt; vertical-align: top;">
                <p>May 4, 2021</p>
            </td>
            <td style="width: 6.8%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 1.5pt; vertical-align: top;">
                <p>By:</p>
            </td>
            <td style="width: 34.96%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">
                <p><i>/s/ Oren Shuster</i></p>
            </td>
            <td style="width: 7.6%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 6.08%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 44.56%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 6.8%; padding-top: 0.38pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p>Name:</p>
            </td>
            <td style="width: 34.96%; padding-top: 0.38pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p>Oren Shuster</p>
            </td>
            <td style="width: 7.6%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 6.08%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 44.56%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 6.8%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">
                <p>Title:</p>
            </td>
            <td style="width: 34.96%; padding-top: 0.75pt; padding-right: 0.75pt; padding-bottom: 0.75pt; vertical-align: top;">
                <p>Chief Executive Officer and Director</p>
            </td>
            <td style="width: 7.6%; padding: 0.75pt; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><u><b>EXHIBIT INDEX</b></u></p>
    <p style="text-align: center;">&#160;</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: top; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">99.1</a></p>
            </td>
            <td style="width: 90%; vertical-align: top; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">News Release dated May 4, 2021</a></p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p><a href="exhibit99-2.htm">99.2</a></p>
            </td>
            <td style="width: 90%; vertical-align: top;">
                <p><a href="exhibit99-2.htm">Consent of Charlton &amp; Company</a></p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><img src="exhibit99-1x001.jpg" style="margin-right: 9pt; margin-left: 9pt; width: 399px;" height="120"></p>
    <p style="text-align: center;"><b>IM Cannabis Announces Proposed Public Offering of Securities</b></p>
    <p style="text-align: justify;"><font style="background-color: #ffffff;"><b>Toronto, Canada, Glil Yam, Israel, May 4, 2021</b> </font><font style="color: #373737; background-color: #ffffff;">-<b> </b></font>IM Cannabis Corp. ("<b>IMC</b>" or the "<b>Company</b>") (CSE: IMCC, NASDAQ: IMCC), a multi-country operator ("<b>MCO</b>") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that it has commenced an overnight marketed offering (the "<b>Offering</b>") of the Company's common shares (each an "<b>Offered Share</b>") on a best-efforts agency basis. The Company may also issue to purchasers of Offered Shares, for no additional consideration, common share purchase warrants (each a "<b>Warrant</b>") that would entitle the holder to purchase common shares of the Company at a price and for a term to be determined in the context of marketing for the Offering.&#160;</p>
    <p style="text-align: justify;">In addition, the Company expects to grant the agents a 30-day option (the "<b>Over-Allotment Option</b>") to purchase additional Offered Shares and Warrants equal to up to 15% of the aggregate number of such securities to be sold in the Offering (excluding the Over-Allotment Option) on the same terms and conditions.</p>
    <p style="text-align: justify;">A.G.P./Alliance Global Partners and Roth Capital Partners have agreed to act as co-lead agents for the proposed Offering in connection with offers and sales in the United States and Roth Canada, ULC will act as the sole agent in Canada. The securities offered under the Offering will be issued and sold in the United States and in the provinces of British Columbia, Ontario and Alberta in Canada in accordance with applicable securities laws. The proposed Offering will be subject to customary conditions and there can be no assurance as to whether or when the proposed Offering may be completed, or as to the actual size or specific terms of the Offering.</p>
    <p style="text-align: justify;">The Company intends to use the net proceeds of the Offering for: (i) supporting growth initiatives in core markets of Israel, Germany and Canada; (ii) additional strategic mergers and acquisitions opportunities; and (iii) general working capital purposes.</p>
    <p style="text-align: justify;">The Offering will be conducted pursuant to the Company's effective shelf registration statement on Form F-10 (File No. 333-254255) (the "<b>Registration Statement</b>") filed with the U.S. Securities and Exchange Commission (the "<b>SEC</b>") and a corresponding Canadian base shelf prospectus (the "<b>Shelf Prospectus</b>") filed with the securities regulatory authority in each of the provinces and territories of Canada.&#160; The Company has filed a preliminary prospectus supplement (the "<b>Preliminary Prospectus Supplement</b>") in Canada, which will also be filed with the SEC, and will file a final prospectus supplement with Canadian regulatory authorities and the SEC in due course.</p>
    <p style="text-align: justify;">A copy of the Preliminary Prospectus Supplement and Shelf Prospectus can be found on SEDAR at <font style="color: #0000ff;"><u>www.sedar.com</u></font> and a copy of the Registration Statement can be found on EDGAR at <font style="color: #0000ff;"><u>www.sec.gov</u></font>.</p>
    <p style="text-align: justify;"><i>This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Offered Shares or Warrants in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.</i></p>
    <p style="margin-bottom: 0pt; text-align: justify;"><b>About IM Cannabis Corp.</b></p>
    <p style="margin-top: 0pt; text-align: justify;">IMC is an MCO in the medical and adult-use recreational cannabis sector, headquartered in Israel and with operations In Israel, Germany and Canada. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;">In Europe, IMC operates through Adjupharm GmbH ("<b>Adjupharm</b>"), a German-based subsidiary and EU GMP-certified medical cannabis processor and distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.</p>
    <p style="text-align: justify;">In Canada, IMC operates through Trichome JWC Acquisition Corp. ("<b>JWC</b>"). JWC is a licensed producer located in Kitchener, Ontario, selling cannabis flower, pre-rolls, hash and kief in the Canadian recreational cannabis market under the JWC and Wagners brands. JWC operates with high standards for providing clean, consistent, aeroponically-grown premium cannabis products to medical patients and the adult-use market throughout Canada and the world. On March 31, 2021, IMC entered into a definitive agreement to acquire MYM Nutraceuticals Inc. ("<b>MYM</b>") and its licensed producer subsidiary, Highland Grow Inc. This transaction, if completed, will reinforce IMC's goal of being a leading global premium cannabis producer and purveyor.</p>
    <p style="text-align: justify;"><i><b>Disclaimer for Forward-Looking Statements </b></i></p>
    <p style="margin-bottom: 0pt; text-align: justify;">This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and United States securities laws (collectively, "<b>forward-looking information</b>"). Forward-looking information are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", "likely" and "intend" and statements that an event or result "may", "will", "should", "could" or "might" occur or be achieved and other similar expressions. Forward-looking information in this press release includes, without limitation, statements relating to the Offering, including the terms, timing, potential completion and the use of proceeds of the Offering.</p>
    <p style="margin-top: 0pt; text-align: justify;">Developing forward-looking information involves reliance on several assumptions and considerations of certain risks and uncertainties, some of which are specific to IMC and others that apply to the industry generally.</p>
    <p style="text-align: justify;">The risk factors and uncertainties that could cause actual results to differ materially from the anticipated results or expectations expressed in this press release, include, without limitation: the ability of IMC to satisfy the conditions to closing of the Offering; that the Offering may not be completed on the terms and timeline indicated, or at all; that the Company's use of proceeds of the Offering may differ from those indicated; additional financing requirements; IMC's ability to realize future net revenue and EBITDA; the ability of IMC to complete its acquisition of MYM; the Company's inability to capture the benefits associated with its acquisition of Trichome Financial Inc. ("<b>Trichome</b>"); risks related to Trichome's lending operations; a resurgence in cases of COVID-19, which has occurred in certain locations and the possibility of which in other locations remains high and creates ongoing uncertainty that could result in restrictions to contain the virus being re-imposed or imposed on a more strict basis, including restrictions on movement and businesses; the extent to which COVID-19 impacts the global economy; the success of new COVID-19 workplace policies and the ability of people to return to workplaces; the Israeli government deciding to delay or abandon the legalization of adult-use recreational cannabis in Israel; the ability of the Company to comply with applicable government regulations in a highly regulated industry; unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture or use of medical cannabis in Israel, Germany and other foreign jurisdictions in which the Company intends to operate; unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture or use of adult-use recreational cannabis in Canada; engaging in activities considered illegal under United States federal law; risks of product liability and other safety-related liability as a result of usage of the Company's cannabis products; any failure of IMC to maintain "de facto" control over Focus Medical Herbs Ltd. ("<b>Focus Medical</b>") in accordance with IFRS 10; the Company and Focus Medical having to rely on third party cannabis producers to supply the Adjupharm and Focus Medical with product to successfully fulfill previously announced sales agreements and purchase commitments; the ability of Adjupharm and Focus Medical to deliver on their respective sales commitments; the risk that regulatory authorities in Israel may view IMC as the deemed owner of more than 5% of Focus Medical in contravention to Israeli rules restricting the ownership of Israeli cannabis cultivators and thereby jeopardizing Focus Medical's cannabis cultivation license; any inability of the Company to comply with and maintain in good standing with the Israeli Ministry of Health and/or the Israeli Medical Cannabis Agency any licenses required to conduct its operations; any unexpected failure of Focus Medical to maintain any of its commercial facilities or land lease agreements; any unexpected failure of Adjupharm to renew its production, wholesale, narcotics handling or import/export licenses, permits, certificates or approvals; any unexpected failure of Focus Medical to renew its cultivation license with the Israeli Ministry of Health on similar or better terms; any failure to obtain the requisite business permits in the State of Israel; reliance on management; inconsistent public opinion and perception regarding the use of cannabis; the Company's ability to maintain or improve the brand position of the IMC brand in relevant cannabis markets; political instability and conflict in the Middle East; adverse market conditions; the ability of the Company to access future financing if needed or on terms acceptable to the Company; dilution of shareholders' holdings from future issuances of the Company's securities; the lack of merger and acquisition opportunities; the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; crop failures; litigation; interest rate and currency fluctuations; increasing competition; industry consolidation; failure to meet the continued listing requirements of the Nasdaq Capital Market and the Canadian Securities Exchange; and loss of key management and/or employees.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify;">Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.</p>
    <p style="text-align: justify;"><b>CONTACTS:</b></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Oren Shuster</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">CEO, IM Cannabis Corp.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">+972-77-3603504</p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #0000ff;"><u>info@imcannabis.com</u></font></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Caitlin Kasunich</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Media Relations - U.S.</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">+1 212-896-1241</p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #0000ff;"><u>ckasunich@kcsa.com</u></font></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Gal Wilder</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Media Relations - Canada</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">+1 416-602-4092</p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #0000ff;"><u>gwilder@cohnwolfe.ca</u></font></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Elizabeth Barker</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Investor Relations</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">+1 212-896-1203</p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="color: #0000ff;"><u>ebarker@kcsa.com</u></font></p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>

<head>
    <title>IM Cannabis Corp.: Exhibit 99.2 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <div>
        <div style="text-align: center;"><img src="exhibit99-2xu001.jpg" width="721" height="253"><br></div>
        <p style="text-align: center;">&#160;</p>
        <p style="text-align: center;"><b>CONSENT OF CHARLTON &amp; COMPANY</b></p>
        <p style="text-align: justify;">We hereby consent to inclusion of our audit report dated September 26, 2020 with respect to the consolidated financial statements of MYM Nutraceuticals Inc. as at and for the years ended May 31, 2020 and 2019 in the prospectus supplement of IM Cannabis Corp. (the &#8220;<b>Company</b>&#8221;) filed pursuant to General Instruction II.L of Form F-10, which forms part of the Registration Statement on Form F-10 filed by the Company with the United States Securities and Exchange Commission (File No. 333-254255).</p>
        <p style="text-align: justify;">Yours truly,</p>
        <p style="text-align: justify;"><img src="exhibit99-2xu002.jpg" width="342" height="51"></p>
        <p style="text-align: justify; margin-bottom: 0pt;">Charlton &amp; Company</p>
        <p style="text-align: justify; margin-top: 0pt;">CHARTERED PROFESSIONAL ACCOUNTANTS</p>
        <p style="text-align: justify;">May 4, 2021</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !X 8\# 2(  A$! Q$!_\0
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MFOO."\%K4Q37DOU/GL\K?#20VO9?V _^3J_#/^]/_P"B7KQZXAE@91-&T9=
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ME5?H?F;^WU_R=7XE^L/_ **6F_L!_P#)UGAC_>G_ /1+TO[?7_)U7B7ZP_\
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MPUH=GAH=-MPW9BNX_K4^EJ-M73UK:C1A2ARP5D?(XO,L75D^:H_O!55%VJ,
M= !@"E[4E.AC>618HU9W=@JJHR23T K1M15V><KSDENV?0G[".A%9=:\1,F
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M$9KVU:$%F9< ;@,G@]*^ZUI-OM3JSS/,:F88CVU16=K:%X7#1P]/D3N?/?\
MP4<\)^(O%GP1MX/#FE7.I3VFI1RR06L9DDV889"CD\D=*^&4^$?Q1=@H^'GB
M7+' SIDH_P#9:_6K INWVKTLLXCQ&7X?V$()J]]3FQ66PQ%3G;LSE?@5I=[H
M?P7\)Z-J4/DWFGZ):6]Q$?X)$B56'X$&NLHHKP*DW.;F]V>A&/+%(:P'I7PE
M_P %!_@KXHF^,'_"6^$_#5_JEIKD0:Z%A;M*8IU 4E@H)&X8/X&ON^D('I7;
MEF95LOQ'MJ2OTL88K"PQ%/DD?E+X4^"/Q0UGQ+9:6? VO6JW4Z1O/<V$D<<2
MDX+,S   #)_"OU!\ Z%:>&?!NF>'[% EOIMI'!& .RKC-;6!Z4A'M73FV=U\
MRY545E'L98/ 0PMVG=L,BD-.Q17C'<?GA^W)\,OB!JO[2&N:MI7@_6-1L;U8
M7@N+.S>5& C4$94'!!%'[#?PR^(.E?M):'JVJ^#]9TZQL5FDGN+RS>%%!C91
MRP&3EAQ7Z&X]J,>U?2/B;$_4OJG(K6M<\K^RJ?M_:\W6XBYQS2D"G45\T>J>
M2_M,? ?PK\7M(5KT?8-:MUVVFI1+\RC^ZX_B7^7:OA?XM?LV_%3P'<2M/H$N
MK6*GY;W3%,RE?5E W+^(K]0OPI,#TKW<LX@QF CR0=X=F>?BLMHUW?9]S\:+
MJUN[9RES;30L.")(RO\ .HU5B<#D^U?L1JGAW0=3<MJ6B:?=L>\]JDA_4543
MP3X/C8/'X4T167H5T^($?^.U]''C=6UHZ^O_  #S7D;_ )_P/RA\'>!_&'BN
M]6T\.^&]2U"1CC]Q;,5'U;& /<U]4?LW_L:W2WUOKWQ2DB\J,ATT>W<DL?25
MQ_(?G7V?:6L%M"(K>".&->B1H% _ 5+BO*S#BW&8F+A27(G]_P!YUX?)Z--J
M4G=E?2[*TTZPAL;&WCM[:W01Q11J%5% P  .@JS2 4M?*ZO5GKI);!2$4M%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ /-%%% !1110 4444 %)CWHHH ,>]+110 48HHH
D ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>exhibit99-2xu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*MI$E%%%?+GOA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/=M=1/!=0+JL4L4@(9&73\%2.Q!!%>3C\3^YO1GK=;'?A*+YW[2.EF?FWMY
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MP>58'_."#7]&2?='TKYC/&G*G;S/<RI-*:9)1117S![P4444 %%%% !1110
M4444 %%%% !1110 444TN!WH =13/,7U]Z#(HZG% #Z*:LBMT.:#(HZF@!U%
M1^?'C.\8IV]?6@!U%1^<@P=PP>E+YR<?,.: 'T4WS%SC/-.H **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+L4MM)&6QG@]-H/2N[[UZ-#VG)>H]?ZL9RM?0=111762%%%% !1110 4444
M%%%% !1110 5'+D+D=:?D4@(;M2>P'F<GA'5UTE[:&+R6^T>=:@7FXVS^61N
M+%/WB;B?E/.#] -[1M(U"U\2W=Y(%AMIHR)E$F\2R#8$=1C*?*K C)R<8Z9K
MKMBGL/RI=H]*YU1BG<KF9Y+9>!];L+FYG5(GS.D@CEE4;]EXTX"%5X&QF^]D
MY(Z $U8UCP/JVK7 NOW,3$SRO;>8,/NF@<1E]N1E8B-PZ$]Z]1VKZ4;1_=%9
M_586M=AS,\Q'@W6K>ZEE@>)#=_:8?,W -:K-=-(SC ^<E"N 3PR\<$U2NOAO
MJQ2WMHVMVLK&*>&!<A0\+SP2+%C!V *DD8(/R[5->M;1Z=*78OH*/JL'U8<S
M//\ 3?#=^VJ6[R6D5LMOJEQ?FY+@NR2"0! !W^<9R<?+W[3VOA^]A\0:E(L:
MKIMT)7=)Y%DW2-MPR?+N48!R"2.F*M_$C5;O1_#J365Q]EF:[MXC+N1<(TJJ
MW+JRC@GDCBN.A\9:K>:*[7>I/IM_'8K):JL",M],-X8@%?G!91@)M)!## (K
M"?)"7LW?N6NY<_X0#4$FTV4"'R[2ST^.2U! \UX'=FPVW*X+(P(Z[=IX.1&O
MA'6ETJ*W\N8/!J!N59)8/N;I/N93CAQD/G\*U_#/B+4-0\2/;W4["R*N]N=J
MXED&!)%N Y\HY /!;/?82:+>+;][?7)=.OO[8BC<0PM$B.ULV',CE4'*#"@!
MN20<G!J+4N7FLU<#I=)T&2#Q(^I20QJCZ?#!\VW>)%>1FSM&.CCD5U2UY[X9
M\0WVH:[IBFZ>>WN-/62:#"9AEVQG+*%#+D%NI.<]!BO0%;=FNVARN+Y3-[CZ
M***ZA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-]TTM% 'E7B[Q#._Q
M*L/#EWJTGA_2)M+>\ANHY4B-[.)-K1!V!QY:88@<GS >BFN7UWQWXFT?1?'2
M::LVK6FFS01VVL&ZAW1(;2V<G: -^2[/D#G>:]OO-*M=2C$=W:P748.0LT8<
M9]<$4JZ?;K$T0@B$;8W)L&#@8&1] /RJU-=C/D?<\*\0?%;6K7QI?WD!N(_"
M$B7FBVMP$C\DWT4;.)@V=V?-CG@P1@M&N.M<WX3\6>(M>^'/C"^O/$6KV%_I
MOA^#4+2VN)8A=><;)I7N,H"K0.^W:.<,D@..@^F6TVU:'RFMH6BSN\LH-N<Y
MSC'7-+_9MM_S[0_ZORON#[G]WIT]JKGC;87)+JSQH7FIZ=\7)-%;5M3N=-@T
MW3[E?-U&*/;)+-=!RRD;I,B*,8'ICO7GZ?$SQ-!X!URZ;5=3L]1'AS3[^%;^
M2#?-+))^]N+8J"HCP0IW'*G&57^+Z?N-"T^\N8[F>PMIKB/&R:2)6=<'(P2,
MCFG3:/9W$826S@EC"E KQ*0%.,C!'3@<>U'.NPN27<\.;7+A_$0LK[Q;?>'[
M)-%GO3(VI0S%)1,%#E]I5@%YV].>:MZQXQ\2S_"SX;ZA=I?6FKZQ=VD>H6^F
M>7'<2;[>1F5?,(522%;!(Q@CVKUU/"NCQF/;I-BOEG<F+9!M/'(XX/ _*M"2
MW2;;OC5]IW+N .#ZCWY-+G5[I!R.SU/F_0O%GC/1_$VD67B/4+ZWN%U*SM+J
M[=X!8(K6WF&"7'/G.2JA@ A=@ W(4WM.\>ZS?6/A_5XO$4K^)[O6_L-]X78(
M4CC\TI-$$V[U,,8,GF$_-LR<A@*]_>PMYPXD@C<.06W(#N(Q@GUZ#\J:NEVD
M=VUTEK MTR[6F6,!R/0MC..*KVB?07LY+2Y\W6_B;Q2GASX=WMW<ZLCZW)&;
MII-4A3[2OV":4E&*XB&\(VTX/ 'M6Y?>+M7TG7M1L6U^/.H64L>C7BZC#-#8
MRI9AL7B;<J0ZL_F@L#N48&54^Y76BV-[;1V]S96UQ;Q_<BEB5T7 P, C XJ.
M/P[ID._R].M(]\?E-M@4;DQC:>.1CM2YUV#D?<^>+CXL>(;6.5-+%Y<:AI^B
MZY)<V5Q+'=I+>0'3V1XI44>:BK<.1T/S,I (P+'B;Q5K%MJ&G6'A/QW/JMMJ
MMG ]QJDOD7 T^1KVUCBF 50,2B68&,\'8=NW!KZ%M]*M+-8U@M8(%C!1%CC"
MA0<9 P. <#\A26^C65JDBP6=O"LC^8ZQQ*H9LYW' Y.><T<ZZ(:A+JSPJX^+
M&OW$VO:')#<6/BW[/I^F1:=;JK"*[D:[,MS;E\!T\B(S+N.,1;3@@BMOX=?$
MNZU6]\,0ZS="RNETS4+?4K:=D0F^M[BWB9CSP3N=@ <8D%>P&RA:83&&,RCH
MY49[]_Q/YFJMWX>TW4&!N=.M+DJQ8&:%6P3C)Y'7@?D*'*+5K#49)[GDWQ2^
M)>KZ)XSL9-,CNFT#0&AEU^6&-&B\N=MA#DG</)B8SG:#_P L^Q-5])\8W^I>
M%=;\1-J\[^)M.EU%8/"\<\:*9(?.$-NT>W<Q941\YR<@@[>*]I;3K=TF5H(2
MLW^M4H,/QCYO7@8Y[5$=%LC>"[^Q6QNU&!/Y2[P,8QNQGI2YU;8.25]SQ'5/
M%W]G>#=%UBQ\;37ZZG-:Q:E?B6!ELX)&427"QA<1X;;'D\)ORV=IJM<>/M4T
M'QE'8P^)6U+PO#K6GQ2:E.4(B\Z&Y\RU>8*%8!EMV!^\IE52>E>[0Z'80/,\
M5C;1O,,2LD*@R9Z[N.?QI1HM@MH;065L+0C!MQ$OE^OW<8IJ2["Y7<\2O/''
MBNZ\6+-H%TNK65M<ZE.VGJ$(O[:$V:&.)^@=6FD*G."R[3P<B+1=6OO& \#:
MC'XCUBWL]<U/48I8T<0YAC%TT2[2N4*^6@/?C![U[M;Z=;6B1I#;Q0K$NQ%C
M0*%7C@8Z#@?E3_L4/R?ND^0EE^4?*3G)'IG)_.ESQ[#Y/,^:]2^*/B:9M>DB
MOKS2M&UJS8>'=2DAA=8C!*L?F(<G?YT;F<;P.%_/3USQAXFU30OB'#J-Y>:#
MX@\*^'H[HK8G;"]QMO"+B,E?FBD$49VGH5*D<'/OC:5:R1Q1O:P/'%_JU:,$
M)QC@8XXXJ9K..0.&CC8.NU@5!W#G@^HY/YT<ZZ(2@^K/$+[6-3\)Z]X8>ZUV
MZU#1[M+))+>.^B%]'<S2A!(\3K^]@?*J0I#+AR V?D]U7[B_2J;Z59R74=R]
MG ]S&-J3-&"Z#T!QD"K]2W<N,>4****DL**** "BBB@ HHHH **** "LCQ!J
M_P#8.G3WS1M)#!M:3;CY4W ._P!%4EC]*UZJW=K%>6\UO,F^&52CJ>A4C!'Y
M5$KM:#1RUU\0+2SN[>.2-]DUZ;19=PV[050R>ZB5UC]<G/3-5C\3["&.X-Q%
M-;O!<3Q2HP!8)&DK^:N/O*PA;&._!Y!K3/@'16LS:M:;HC:I:#<Q+(BEB"I[
M-EB=PY)QZ5)>>!-%OVMC<68G-N9RAD8G(F#B13Z@B1N#7(XXCHT/W2"Y\57U
MK-;6TFF;;N[8BVB%PIR I9BY ^7  SC=RPQFH+'Q_%=B]1[6:&:SMY9IXV(R
MK1L59,]#G&0>F"*T#X,LI8(DDGO9&@??!,UPQDA.TK\K=>A(.<Y[YJ*7P#I+
MQ(H2>/"212&.=PTRNVYPYSELGG/7TQ1RU^X:&/=?$^*UTF2^:T<20^>9K>21
M5\I8\?.S= &W1D>S@]C3Q\1U_M&SM&AMIA<>5AK2]64MYDCHNP;1O \MF;T'
MK6S=>"]*O/[2+0-&^H1I%/)&Q5B%&%QZ'&.GH*:_@JRG.^9[BXN,1[;B24^8
MI1G92",8(+M]0<&ERXF^Z'[H>+_%:>%M/@NRL;K+.L \V81("<G)8@XZ?K5;
M1?&<GB.*&33+(R1[(7G:>0(8O,17V@ '<P5E)Z#GJ:NS^%8;W3;>UN[FYF>&
M?[0EP'VN'R2,'T ;'T%-L/!6G:/)$U@L]F$1$9(9F"RA!A=X[G'?J>YJ[5?:
M7VB+0FUOQ!!HL]FMTFVVN/,'GDC:C*A?!^JJYS_L^]84OC2]A;=+HC*GV07K
M*EP#*D>1PR%1@\M@9Y*-BNDUS0[/Q!9K:WL1EA61)0N2/F5@PY'TP1W!([U'
M<^&[*Z-X)8W<7;(TP+'Y@H "?[O'W>AW-ZFJG"I+X6"DC-D\5(/"=SX@CLII
MK2.)[B-59=TD(!(DP2, J,X/..V>*CO/&]I8:AJUI+;2"2QA65-N";@D*2B>
MX+Q@_P#71:V%\-6(TB]TP1L+.[$HDCW'@29W!?0<GIZU#=^#]+O+\7<UMYD_
MG&?>6/#&(1'\-JKQZ@'M4RC5LN7<=S'T7QY:ZOK5O8Q6YB,R*RL9%+9,*38V
M]<;7'S>H(KM4&,UA:?X4L-,N(IH8Y#)! MM"TCEO+C4 ;5';.T9/4UO9XK2B
MII6J;DL6BBBN@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
2%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>exhibit99-2xu002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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MRN&'0J1R&4]B#R#7S-8?LFW$GQ@:#4KW6+[PE!8+Y=_+=*))&&!Y!8<A>6X
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MA\(V?S)$H)(-S-TWDX&W^$=A7TWX%^'FHVVK)XB\3:A]MUD0^5!9VI*65@F
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M?)N[TDQPCMM0D\@=SZ\8KK/&WPCT/Q[XB\.ZOJB3-/HDWG01(0(Y#D$!QCD
MJ#Q7=8&.!0M #-HQCM7B.L?L[RZKX_UK4?\ A(;NT\-:TRS:AI5HQC:XD QM
M+C^ \DXYY->Y;1Z4F!Z4 9VA:%8^&]+M].TVUCL[*W4)%!"NU5'L*T<&G4F1
M0 F#C%(%%/IJT +T%!QWI,^M)0!SOB+P#X=\7-&VM:-9:F\?"O<0JS#Z'K6C
MI.B6&A6HM=.LX+&V'2*WC5%SZX K3R*3B@ "BE P:3=1NH 1OFP*5NM.IO%
M!_#6;X@T:+Q!H>H:9.[QPWMO);.T>-P5U*DCWP:TOYTZ@#D_AMX#M/AKX.T[
MP[932W-O9JP$TV S$L6)(''4UU?>DZ&E[<4 (3FC;3J* $VT;:.?:DR: &R8
MVFO%?V>T%]X@^)FL2G=>7'B"6!F/4)&H"CZ<U[4_)KQOQ)\#=7M_$.J:WX(\
M63^%;K5'\R\M3"LMO*V,%P#]UNISSUH R?ARS>./VCO&OB3/FV.AVZ:-:..1
MO)S)CZ%6_.O?%KBOA3\-+3X8>%UTNWF-W<RR-<7=XXPUQ,WWG([=N/:NU52*
M %R**3;10!%%]P4I4 ]*** !*?110 C=*#U%%% "T444 .7I1@444 )_#2CI
M110 G\-"T44 .I!U-%% "TU:** !>M#444 )2K110 E%%% "_P 5.HHH :U)
M110 ^F444 *.M+WHHH ;2K110 ZBBB@ HHHH 3 HP*** $[BG444 %%%% '_
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
